KRAS and colorectal carcinoma: Mutant KRAS was not significantly correlated with microsatellite instability (MSI) status, and correlated with shortened median overall survival (OS) in CRC patients (59.93 vs. 78.73 months) (n = 1965, cBioportal) (Fig. S5c-d).